Everlywell

We believe the future of healthcare is consumerized, accessible, and autonomous and were delighted to discover Everlywell. We convinced Julia to take our check although her seed round was full.

We were able to help bring Series A investor back to the table when the deal almost didn't go through, negotiate valuations of financing rounds, and convince a COO to join.

Julia later became a SoGal Fund I & II LP.

Everly Health became a unicorn in Q4 2020 and its valuation has  grown 240X since we invested in 2017.

In 2024, 1 out of 86 US households had an Everlywell-branded test.

‍